AstraZeneca’s Soriot: UK’s Pharma Policies Have Already Hit Investment

Life Science Strategy Not Being Supported

 
• By Andrew McConaghie
  
AZ courtyard
AstraZeneca opened its new R&D and global HQ in Cambridge, UK in 2021, but has now warned the country could lose out on further investment. • Source: AstraZeneca
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip